IL33 and autoimmune uveitis: Previous studies have shown that IL-33-induced M2 macrophage polarization reduces retinal inflammation and even ameliorates experimental autoimmune uveitis (61), underscoring its potential as a therapeutic target in ocular inflammatory diseases.